Orlando Oliveira - Jun 10, 2025 Form 4 Insider Report for Zenas BioPharma, Inc. (ZBIO)

Role
Chief Commercial Officer
Signature
By: /s/ Jeffrey Held, Attorney-in-Fact
Stock symbol
ZBIO
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 04:37 PM
Previous filing
Dec 18, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Oliveira Orlando Chief Commercial Officer C/O ZENAS BIOPHARMA, INC., 852 WINTER ST., SUITE 250, WALTHAM By: /s/ Jeffrey Held, Attorney-in-Fact 2025-06-12 0001699305

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBIO Stock Option (Right to Buy) Award $0 +100K $0.00 100K Jun 10, 2025 Common Stock 100K $11.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service.

Remarks:

Chief Commercial Officer